SCHEMBL2384483

SCHEMBL2384483

CCOC(=O)[C@H](Cc1ccccc1)N(N[C@@H](Cc1cc(C)ccc1OC)C(=O)O)C(=O)OCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
ALDH1A1 P00352 3/20 0.39
GAA P10253 1/20 0.39
FPR2 P25090 1/20 0.39
ABCB1 P08183 2/20 0.38
CAPN1 P07384 3/20 0.38
ALOX15 P16050 1/20 0.38
RECQL P46063 1/20 0.37
POLB P06746 1/20 0.37
TP53 P04637 1/20 0.37
ITGA4 P13612 1/20 0.37
ITGB7 P26010 1/20 0.37
PTGER1 P34995 1/20 0.37
PTGER4 P35408 1/20 0.37
PTGER3 P43115 1/20 0.37
PTGER2 P43116 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.36
TACR1 P25103 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907923 0.94 ALDH1A1 (0.41) KMT2AMEN1ALDH1A1GAAFPR2
SCHEMBL2385510 0.91 ALDH1A1 (0.46) KMT2AMEN1ALDH1A1GAAFPR2
SCHEMBL2386831 0.90 ITGA4 (0.47) KMT2AMEN1ALDH1A1GAAFPR2
SCHEMBL2385817 0.87 KMT2A (0.50) KMT2AMEN1ALDH1A1FPR2CAPN1
SCHEMBL2386290 0.87 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1CAPN1ALOX15
SCHEMBL2385964 0.86 ATM (0.43) ABCB1POLBTP53TACR1
SCHEMBL2385988 0.86 MMP8 (0.44) ALDH1A1ABCB1POLBTP53TACR1
SCHEMBL2385104 0.85 POLB (0.50) KMT2AMEN1ALDH1A1ABCB1POLB
SCHEMBL2386217 0.84 ALDH1A1 (0.48) KMT2AMEN1ALDH1A1GAAFPR2
SCHEMBL2385820 0.84 ABCB1 (0.40) ALDH1A1ABCB1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017378-B2 Method for production of optically active biphenylalanine compound or salt or ester thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-09-13 US disclosed
US-20090011475-A1 Method For Production of Optically Active Biphenylalanine Compound or Salt or Ester Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090011475-A1 Method For Production of Optically Active Biphenylalanine Compound or Salt or Ester Thereof DNPEP, APEH, PAH KMT2A 433/4885MEN1 1396/4885ALDH1A1 755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.